These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8380218)
1. Eosinophilia-myalgia syndrome: lessons for public health researchers. Taylor R; McNeil JJ Med J Aust; 1993 Jan; 158(1):51-5. PubMed ID: 8380218 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome. Daniels SR; Hudson JI; Horwitz RI J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957 [TBL] [Abstract][Full Text] [Related]
3. Eosinophilia-myalgia syndrome: coming to grips with a new illness. Kilbourne EM Epidemiol Rev; 1992; 14():16-36. PubMed ID: 1289111 [TBL] [Abstract][Full Text] [Related]
4. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. Slutsker L; Hoesly FC; Miller L; Williams LP; Watson JC; Fleming DW JAMA; 1990 Jul; 264(2):213-7. PubMed ID: 2355442 [TBL] [Abstract][Full Text] [Related]
7. The eosinophilia-myalgia syndrome: lessons from Germany. Mayeno AN; Gleich GJ Mayo Clin Proc; 1994 Jul; 69(7):702-4. PubMed ID: 8015338 [No Abstract] [Full Text] [Related]
8. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome. Horwitz RI; Daniels SR J Rheumatol Suppl; 1996 Oct; 46():60-72. PubMed ID: 8895182 [TBL] [Abstract][Full Text] [Related]
9. Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan. Henning KJ; Jean-Baptiste E; Singh T; Hill RH; Friedman SM J Rheumatol; 1993 Feb; 20(2):273-8. PubMed ID: 8474064 [TBL] [Abstract][Full Text] [Related]
10. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique. Shapiro S J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181 [TBL] [Abstract][Full Text] [Related]
11. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. Hibbs JR; Mittleman B; Hill P; Medsger TA Arthritis Rheum; 1992 Mar; 35(3):299-303. PubMed ID: 1536667 [TBL] [Abstract][Full Text] [Related]
12. L-tryptophan and the eosinophilia-myalgia syndrome. Drug Ther Bull; 1990 May; 28(10):37-8. PubMed ID: 2131206 [No Abstract] [Full Text] [Related]
14. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome. Kilbourne EM; Philen RM; Kamb ML; Falk H J Rheumatol Suppl; 1996 Oct; 46():81-8; discussion 89-91. PubMed ID: 8895184 [TBL] [Abstract][Full Text] [Related]
15. L-tryptophan and eosinophilia-myalgia syndrome. Shapiro S Lancet; 1994 Apr; 343(8904):1035-7. PubMed ID: 7909063 [No Abstract] [Full Text] [Related]
16. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Varga J; Uitto J; Jimenez SA Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618 [TBL] [Abstract][Full Text] [Related]
17. [A case of the eosinophilia-myalgia syndrome]. Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794 [TBL] [Abstract][Full Text] [Related]
18. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924 [TBL] [Abstract][Full Text] [Related]
19. L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis. Varga J; Jimenez SA; Uitto J J Invest Dermatol; 1993 Jan; 100(1):97S-105S. PubMed ID: 8423409 [TBL] [Abstract][Full Text] [Related]